Tempus Announces Three Abstracts Accepted For Presentation at the European Society for Medical Oncology Congress 2022
CHICAGO–(BUSINESS WIRE)–Tempus, a leader in artificial intelligence and precision medicine, today announced three abstracts were accepted for presentation at the European Society for Medical Oncology (ESMO) Congress 2022, which convenes...